Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 566

1.

Surgical management, pre-operative tumor localization and histopathology of 80 patients operated for insulinoma.

Andreassen M, Ilett E, Wiese D, Slater EP, Klose M, Hansen CP, Gercke N, Langer SW, Kjaer A, Maurer E, Federspiel B, Kann PH, Bartsch DK, Knigge U.

J Clin Endocrinol Metab. 2019 Aug 1. pii: jc.2019-01204. doi: 10.1210/jc.2019-01204. [Epub ahead of print]

PMID:
31369096
2.

Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.

Ibrahim IS, Brückner C, Carrato A, Earl J, Inderson A, de Vos Tot Nederveen Cappel WH, Mintziras I, Matthäi E, Figiel J, Wasser M, Moreau H, Bonsing B, Slater EP, Bartsch DK, Vasen HF.

United European Gastroenterol J. 2019 Jun;7(5):682-688. doi: 10.1177/2050640619841989. Epub 2019 Mar 31.

3.

ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.

Conrad C, Benzel J, Dorzweiler K, Cook L, Schlomann U, Zarbock A, Slater EP, Nimsky C, Bartsch JW.

Clin Sci (Lond). 2019 Jan 11;133(1):83-99. doi: 10.1042/CS20180906. Print 2019 Jan 15. Review.

PMID:
30635388
4.

Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1).

Lopez CL, Joos B, Bartsch DK, Manoharan J, Albers M, Slater EP, Bollmann C, Roth S, Bayer A, Fendrich V.

World J Surg. 2019 Mar;43(3):831-838. doi: 10.1007/s00268-018-4839-8.

PMID:
30600364
5.

German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program.

Franke FS, Matthäi E, Slater EP, Schicker C, Kruse J, Bartsch DK.

Hered Cancer Clin Pract. 2018 Nov 29;16:17. doi: 10.1186/s13053-018-0100-6. eCollection 2018.

6.

The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer.

Bartsch DK, Gercke N, Strauch K, Wieboldt R, Matthäi E, Wagner V, Rospleszcz S, Schäfer A, Franke FS, Mintziras I, Bauer C, Grote T, Figiel J, Di Fazio P, Burchert A, Reinartz S, Pogge von Strandmann E, Klöppel G, Slater EP.

J Clin Med. 2018 Sep 20;7(10). pii: E295. doi: 10.3390/jcm7100295.

7.

Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model.

Manoharan J, Fendrich V, Di Fazio P, Bollmann C, Roth S, Joos B, Mintziras I, Albers MB, Ramaswamy A, Bertolino P, Zhang CX, Slater EP, Bartsch DK, Lopez-Lopez CL.

Neuroendocrinology. 2018;107(3):257-266. doi: 10.1159/000492224. Epub 2018 Jul 19.

PMID:
30025403
8.

Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.

Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, Mitcheson L, Astbury M, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Finch E, Forshall S, Glasper A, Morse G, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Morris J, Mosler F, Mutz J, Pauli R, Poovendran D, Slater E, Strang J.

Contemp Clin Trials. 2018 Aug;71:124-132. doi: 10.1016/j.cct.2018.06.008. Epub 2018 Jun 13.

PMID:
29908336
9.

Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.

Fendrich V, Jendryschek F, Beeck S, Albers M, Lauth M, Esni F, Heeger K, Dengler J, Slater EP, Holler JPN, Baier A, Bartsch DK, Waldmann J.

Oncogene. 2018 Apr;37(14):1845-1856. doi: 10.1038/s41388-017-0100-4. Epub 2018 Jan 25.

PMID:
29367759
10.

Preoperative Imaging Overestimates the Tumor Size in Pancreatic Neuroendocrine Neoplasms Associated with Multiple Endocrine Neoplasia Type 1.

Polenta V, Slater EP, Kann PH, Albers MB, Manoharan J, Ramaswamy A, Mahnken AH, Bartsch DK.

World J Surg. 2018 May;42(5):1440-1447. doi: 10.1007/s00268-017-4317-8.

PMID:
29075857
11.

Persistent Heparin-Induced Thrombocytopenia Treated With IVIg.

Azimov MB, Slater ED.

Chest. 2017 Sep;152(3):679-680. doi: 10.1016/j.chest.2017.05.044. No abstract available.

PMID:
28889885
12.

Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small Intestine.

Heverhagen AE, Legrand N, Wagner V, Fendrich V, Bartsch DK, Slater EP.

Neuroendocrinology. 2018;106(4):312-317. doi: 10.1159/000480121. Epub 2017 Aug 19.

PMID:
28848144
13.

An unexpected finding of hepatic lymphoma after emergent cholecystectomy.

Steen ST, Slater ED, Barbaro CE, Huebner ER.

J Surg Case Rep. 2017 Mar 7;2017(3):rjx051. doi: 10.1093/jscr/rjx051. eCollection 2017 Mar.

14.

Is Routine Screening of Young Asymptomatic MEN1 Patients Necessary?

Manoharan J, Raue F, Lopez CL, Albers MB, Bollmann C, Fendrich V, Slater EP, Bartsch DK.

World J Surg. 2017 Aug;41(8):2026-2032. doi: 10.1007/s00268-017-3992-9.

PMID:
28321559
15.

Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.

Albers MB, Librizzi D, Lopez CL, Manoharan J, Apitzsch JC, Slater EP, Bollmann C, Kann PH, Bartsch DK.

World J Surg. 2017 Jun;41(6):1521-1527. doi: 10.1007/s00268-017-3907-9.

PMID:
28138732
16.

Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.

Goehringer C, Sutter C, Kloor M, Gebert J, Slater EP, Keller M, Treiber I, Ganschow P, Kadmon M, Moog U.

Fam Cancer. 2017 Apr;16(2):303-309. doi: 10.1007/s10689-016-9952-y.

PMID:
27838800
17.

Refinement of screening for familial pancreatic cancer.

Bartsch DK, Slater EP, Carrato A, Ibrahim IS, Guillen-Ponce C, Vasen HF, Matthäi E, Earl J, Jendryschek FS, Figiel J, Steinkamp M, Ramaswamy A, Vázquez-Sequeiros E, Muñoz-Beltran M, Montans J, Mocci E, Bonsing BA, Wasser M, Klöppel G, Langer P, Fendrich V, Gress TM.

Gut. 2016 Aug;65(8):1314-21. doi: 10.1136/gutjnl-2015-311098. Epub 2016 May 24.

PMID:
27222532
18.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
19.

An unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 gene.

Manoharan J, Lopez CL, Hackmann K, Albers MB, Pehl A, Kann PH, Slater EP, Schröck E, Bartsch DK.

Endocrinol Diabetes Metab Case Rep. 2016;2016:160011. doi: 10.1530/EDM-16-0011. Epub 2016 Mar 2.

20.

Autophagy-related cell death by pan-histone deacetylase inhibition in liver cancer.

Di Fazio P, Waldegger P, Jabari S, Lingelbach S, Montalbano R, Ocker M, Slater EP, Bartsch DK, Illig R, Neureiter D, Wissniowski TT.

Oncotarget. 2016 May 17;7(20):28998-9010. doi: 10.18632/oncotarget.8585.

21.

Reciprocal Changes in Phosphoenolpyruvate Carboxykinase and Pyruvate Kinase with Age Are a Determinant of Aging in Caenorhabditis elegans.

Yuan Y, Hakimi P, Kao C, Kao A, Liu R, Janocha A, Boyd-Tressler A, Hang X, Alhoraibi H, Slater E, Xia K, Cao P, Shue Q, Ching TT, Hsu AL, Erzurum SC, Dubyak GR, Berger NA, Hanson RW, Feng Z.

J Biol Chem. 2016 Jan 15;291(3):1307-19. doi: 10.1074/jbc.M115.691766. Epub 2015 Dec 2.

22.

Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.

Bartsch DK, Albers MB, Lopez CL, Apitzsch JC, Walthers EM, Fink L, Fendrich V, Slater EP, Waldmann J, Anlauf M.

Neuroendocrinology. 2016;103(3-4):240-7. doi: 10.1159/000435921. Epub 2015 Jun 18.

PMID:
26113081
23.

Health in Action Program, Brazil: a Program Impact Pathways (PIP) analysis.

Slater E, Lasco ML, Capelli J, Pen G.

Food Nutr Bull. 2014 Sep;35(3 Suppl):S108-16.

PMID:
25902580
24.

Limited resection of pancreatic cancer in high-risk patients can result in a second primary.

Potjer TP, Bartsch DK, Slater EP, Matthäi E, Bonsing BA, Vasen HF.

Gut. 2015 Aug;64(8):1342-4. doi: 10.1136/gutjnl-2015-309568. Epub 2015 Apr 2. No abstract available.

PMID:
25838549
25.

Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas.

Lichtenauer UD, Di Dalmazi G, Slater EP, Wieland T, Kuebart A, Schmittfull A, Schwarzmayr T, Diener S, Wiese D, Thasler WE, Reincke M, Meitinger T, Schott M, Fassnacht M, Bartsch DK, Strom TM, Beuschlein F.

J Clin Endocrinol Metab. 2015 May;100(5):E776-82. doi: 10.1210/jc.2015-1100. Epub 2015 Mar 12.

PMID:
25763608
26.

IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cells.

Münzberg C, Höhn K, Krndija D, Maaß U, Bartsch DK, Slater EP, Oswald F, Walther P, Seufferlein T, von Wichert G.

J Cell Mol Med. 2015 May;19(5):948-59. doi: 10.1111/jcmm.12473. Epub 2015 Mar 8.

27.

Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.

Bartsch DK, Slater EP, Albers M, Knoop R, Chaloupka B, Lopez CL, Fendrich V, Kann PH, Waldmann J.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2387-91. doi: 10.1210/jc.2013-4432. Epub 2014 Sep 11.

PMID:
25210877
28.

MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.

Slater EP, Strauch K, Rospleszcz S, Ramaswamy A, Esposito I, Klöppel G, Matthäi E, Heeger K, Fendrich V, Langer P, Bartsch DK.

Transl Oncol. 2014 Aug;7(4):464-71. doi: 10.1016/j.tranon.2014.05.007. Epub 2014 Jun 21.

29.

The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.

Henrici A, Montalbano R, Neureiter D, Krause M, Stiewe T, Slater EP, Quint K, Ocker M, Di Fazio P.

Mol Carcinog. 2015 Aug;54(8):585-97. doi: 10.1002/mc.22122. Epub 2013 Dec 23.

PMID:
24375802
30.

LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic Cancer.

Slater EP, Fendrich V, Strauch K, Rospleszcz S, Ramaswamy A, Mätthai E, Chaloupka B, Gress TM, Langer P, Bartsch DK.

Transl Oncol. 2013 Apr;6(2):99-103. Epub 2013 Apr 1.

31.

Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumors.

Fendrich V, Maschuw K, Rehm J, Buchholz M, Holler JP, Slater EP, Bartsch DK, Waldmann J.

ScientificWorldJournal. 2012;2012:529151. doi: 10.1100/2012/529151. Epub 2012 Dec 27.

32.

A Web-based communication aid for patients with cancer: the CONNECT Study.

Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB 3rd, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, Slater E, Solarino N, Sulmasy DP, Trinastic J, Weinfurt KP.

Cancer. 2013 Apr 1;119(7):1437-45. doi: 10.1002/cncr.27874. Epub 2013 Jan 18.

33.

Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

Bartsch DK, Dietzel K, Bargello M, Matthaei E, Kloeppel G, Esposito I, Heverhagen JT, Gress TM, Slater EP, Langer P.

Fam Cancer. 2013 Mar;12(1):89-96. doi: 10.1007/s10689-012-9582-y.

PMID:
23179793
34.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group; FaPaCa registry.

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

35.

Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense?

Schneider R, Ramaswamy A, Slater EP, Bartsch DK, Schlosser K.

World J Surg. 2012 Nov;36(11):2598-604. doi: 10.1007/s00268-012-1730-x.

PMID:
22851148
36.

Perspectives on humanism in medicine from the 2012 Edward J. III Excellence in Medicine honorees.

Abrams JS, Owen WF Jr, Brenner JC, Donlen J, Leone P, Carson JL, Slater EE.

MD Advis. 2012 Spring;5(2):4-9. No abstract available.

PMID:
22549607
37.

Clinical impact of TP53 alterations in adrenocortical carcinomas.

Waldmann J, Patsalis N, Fendrich V, Langer P, Saeger W, Chaloupka B, Ramaswamy A, Fassnacht M, Bartsch DK, Slater EP.

Langenbecks Arch Surg. 2012 Feb;397(2):209-16. doi: 10.1007/s00423-011-0868-6. Epub 2011 Dec 29.

PMID:
22203015
38.

Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.

Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K.

World J Surg. 2012 Feb;36(2):318-26. doi: 10.1007/s00268-011-1392-0.

PMID:
22202993
39.

Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: the Fox Chase Cancer Center Partners' initiative.

O'Grady MA, Slater E, Sigurdson ER, Meropol NJ, Weinstein A, Lusch CJ, Sein E, Keeley P, Miller B, Engstrom PF, Cohen SJ.

Clin Colorectal Cancer. 2011 Jun;10(2):113-6. doi: 10.1016/j.clcc.2011.03.007. Epub 2011 Apr 22.

40.
41.

Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumors.

Fendrich V, Rehm J, Waldmann J, Buchholz M, Christofori G, Lauth M, Slater EP, Bartsch DK.

Ann Surg. 2011 Mar;253(3):546-52. doi: 10.1097/SLA.0b013e31820a5bbe.

PMID:
21239987
42.

German national case collection for familial pancreatic cancer (FaPaCa): ten years experience.

Schneider R, Slater EP, Sina M, Habbe N, Fendrich V, Matthäi E, Langer P, Bartsch DK.

Fam Cancer. 2011 Jun;10(2):323-30. doi: 10.1007/s10689-010-9414-x.

PMID:
21207249
43.

Do soft skills predict surgical performance?: a single-center randomized controlled trial evaluating predictors of skill acquisition in virtual reality laparoscopy.

Maschuw K, Schlosser K, Kupietz E, Slater EP, Weyers P, Hassan I.

World J Surg. 2011 Mar;35(3):480-6. doi: 10.1007/s00268-010-0933-2.

PMID:
21190109
44.

Microarray analysis reveals differential expression of benign and malignant pheochromocytoma.

Waldmann J, Fendrich V, Holler J, Buchholz M, Heinmöller E, Langer P, Ramaswamy A, Samans B, Walz MK, Rothmund M, Bartsch DK, Slater EP.

Endocr Relat Cancer. 2010 Jul 28;17(3):743-56. doi: 10.1677/ERC-09-0118. Print 2010 Sep.

PMID:
20562231
45.

PALB2 mutations in European familial pancreatic cancer families.

Slater EP, Langer P, Niemczyk E, Strauch K, Butler J, Habbe N, Neoptolemos JP, Greenhalf W, Bartsch DK.

Clin Genet. 2010 Nov;78(5):490-4. doi: 10.1111/j.1399-0004.2010.01425.x.

PMID:
20412113
46.

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.

Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matthäi E, Sina M, Hahn SA, Bartsch DK.

Fam Cancer. 2010 Sep;9(3):335-43. doi: 10.1007/s10689-010-9329-6.

PMID:
20195775
47.

Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.

Bartsch DK, Langer P, Habbe N, Matthäi E, Chaloupka B, Sina M, Hahn SA, Slater EP.

Clin Genet. 2010 Apr;77(4):333-41. doi: 10.1111/j.1399-0004.2009.01352.x. Epub 2009 Dec 22.

PMID:
20041885
48.

The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.

Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, Slater EP, Maitra A, Bartsch DK.

Gut. 2010 May;59(5):630-7. doi: 10.1136/gut.2009.188961. Epub 2009 Nov 1.

PMID:
19880966
49.

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK.

Gut. 2009 Oct;58(10):1410-8. doi: 10.1136/gut.2008.171611. Epub 2009 May 25.

PMID:
19470496
50.

Expression of the transcription factor snail and its target gene twist are associated with malignancy in pheochromocytomas.

Waldmann J, Slater EP, Langer P, Buchholz M, Ramaswamy A, Walz MK, Schmid KW, Feldmann G, Bartsch DK, Fendrich V.

Ann Surg Oncol. 2009 Jul;16(7):1997-2005. doi: 10.1245/s10434-009-0480-y. Epub 2009 May 2.

PMID:
19412634

Supplemental Content

Loading ...
Support Center